Structure Therapeutics CEO: Obesity drug success comes down to the patient experience
CNBC's Angelica Peebles talks to Structure Therapeutics CEO Ray Stevens about the obesity landscape and why there's still ...
Experts believe dementia patients will more than double in the next decade
"As anyone who has experienced a cancer diagnosis will know, it takes time to adjust to a new normal," the Princess of Wales ...
Firefly Neuroscience Discovers Breakthrough Cognitive Brain Age Biomarker Using its FDA ...
Greg Lipschitz, Executive Chairman of Firefly, said, “This breakthrough underscores our commitment to pushing the boundaries of innovation in brain health, ultimately with the aim of making a ...
Dementia cases expected to double by 2060, study shows
A new study finds that dementia cases are expected to double to 1 million by 2060, with African-American cases potentially ...
US dementia cases predicted to double by 2060 — here’s who is most at risk
Our study results forecast a dramatic rise in the burden from dementia in the United States over the coming decades,” said ...
Introducing FDI, the Florey Dementia Index for Alzheimer's onset prediction
A predictive tool for determining the age at which individuals may develop mild cognitive impairment (MCI) or Alzheimer's ...
What Type of Doctor Treats Dementia and Cognitive Decline?
Learn about the types of providers who treat patients with age-related cognitive decline and dementia and how to get the most out of your initial visit.
China Medical System （00867）Obtained New Drug ZUNVEYL for the Treatment of Mild-to ...
As the second oral therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of Alzheimer’s disease during the past decade, ZUNVEYL demonstrates a potentially better safety ...